2018
DOI: 10.1515/jomb-2017-0022
|View full text |Cite
|
Sign up to set email alerts
|

Prenatal Screening Markers for Down Syndrome: Sensitivity, Specificity, Positive and Negative Expected Value Method

Abstract: SummaryBackgroundGenetic screening for chromosomopathy is performed in the first trimester of pregnancy by determining fetal nuchal translucency (NT), and the pregnancy associated plasma protein-A (PAPP-A) and free human chorionic gonadotropin (free-beta HCG) biomarkers in maternal serum.MethodsWe tested the sensitivity, specificity, positive and negative expected values of each marker with the aim of setting a model for prenatal screening readings. Statistical data treatment has been performed on a sample of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 29 publications
0
4
0
Order By: Relevance
“…7 Prenatal screening for Down syndrome is done in the first trimester between 11 weeks and 14 weeks by ultrasound measurement of nuchal translucency (NT) and the pregnancy associated plasma protein-A (PAPP-A) and free human chorionic gonadotropin (free-beta HCG) biomarkers in maternal serum. 11 The families at risk are mostly identified after birth of affected child, but many genetic disorders occur in families, even without any previous history of affected child.…”
Section: Discussionmentioning
confidence: 99%
“…7 Prenatal screening for Down syndrome is done in the first trimester between 11 weeks and 14 weeks by ultrasound measurement of nuchal translucency (NT) and the pregnancy associated plasma protein-A (PAPP-A) and free human chorionic gonadotropin (free-beta HCG) biomarkers in maternal serum. 11 The families at risk are mostly identified after birth of affected child, but many genetic disorders occur in families, even without any previous history of affected child.…”
Section: Discussionmentioning
confidence: 99%
“…The calculated risks of Down's syndrome and Trisomy 13/18 were determined using the software program based on the gestational age at the time of amniocentesis, maternal age, and the levels of biochemical markers. The performance of each biomarker in detecting chromosomal abnormalities was assessed by calculating the sensitivity, speci city, positive predictive value (PPV), and negative predictive value (NPV) (7).…”
Section: Methodsmentioning
confidence: 99%
“…Only 19% of the Saudi population believes accurately that Down syndrome can be diagnosed through an ultrasound and blood test (Alhaddad et al, 2018). Down syndrome can be detected prenatally in multiple ways (Alkhteeb, 2010;Alrousan, 2018); fetal nuchal translucency and maternal serum PAPP-A and free-beta HCG indicators may be used in the first trimester to screen for chromosomopathy (Durković et al, 2018). Thus, Down syndrome can be detected prenatally through a maternal ultrasound, blood test, and amniotic fluid examination (Alkhteeb, 2010;Alrousan, 2018).…”
Section: General Informationmentioning
confidence: 99%